HM
BIOS

Howard Marks’s BioPlus Acquisition Corp. Class A Ordinary Shares BIOS Stock Holding History

Howard Marks’s Portfolio BIOS Stock Details BIOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-100,000
Closed -$1.06M – 236
2023
Q2 		$1.06M Hold
100,000
– – 0.01% 225
2023
Q1 		$1.04M Hold
100,000
– – 0.01% 274
2022
Q4 		$1.03M Hold
100,000
– – 0.01% 313
2022
Q3 		$1M Hold
100,000
– – 0.01% 341
2022
Q2 		$1M Hold
100,000
– – 0.01% 319
2022
Q1 		$988K Buy
+100,000
New +$987K 0.01% 318

Other funds holding BIOS

WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.04B AUM 31.03% 1-Year Est. Return
WRBC
W.R. Berkley Corp Greenwich, Connecticut $2.1B AUM 13.6% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.72B AUM 70.66% 1-Year Est. Return
LA
Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return
RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.32B AUM 1.82% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
MSU
Mizuho Securities USA New York $6.2B AUM 35.46% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return

Howard Marks's BIOS Position: Q3 2023 in Review

Howard Marks sold out of BioPlus Acquisition Corp. Class A Ordinary Shares (BIOS) in Q3 2023, closing a stake of 100,000 shares — an estimated $1.06M sold.

Howard Marks first reported a position in BIOS in Q1 2022 and held it in 6 quarters. The position peaked at $1.06M in Q2 2023. 30 funds tracked by Wall St. Rank hold BIOS as of Q3 2023.

  • Howard Marks reported no remaining BioPlus Acquisition Corp. Class A Ordinary Shares position as of Q3 2023 after selling out during the quarter.
  • Howard Marks sold 100,000 BioPlus Acquisition Corp. Class A Ordinary Shares shares in Q3 2023, an estimated $1.06M.
  • Howard Marks first reported a position in BioPlus Acquisition Corp. Class A Ordinary Shares in Q1 2022 and held it in 6 quarters.
  • Howard Marks's BioPlus Acquisition Corp. Class A Ordinary Shares position peaked at $1.06M in Q2 2023.
  • 30 funds tracked by Wall St. Rank held BioPlus Acquisition Corp. Class A Ordinary Shares as of Q3 2023.

Based on Oaktree Capital Management's 13F filing for Q3 2023, filed 13 Nov 2023.